PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · IEX Real-Time Price · USD
3.960
+0.110 (2.86%)
At close: Mar 28, 2024, 4:00 PM
4.000
+0.040 (1.01%)
After-hours: Mar 28, 2024, 4:34 PM EDT
PDS Biotechnology Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for PDS Biotechnology stock have an average target of 17.33, with a low estimate of 11 and a high estimate of 21. The average target predicts an increase of 337.63% from the current stock price of 3.96.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PDSB stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $14 → $11 | Strong Buy | Reiterates | $14 → $11 | +177.78% | Mar 28, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +430.30% | Mar 27, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $23 → $20 | Buy | Maintains | $23 → $20 | +405.05% | Nov 15, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +430.30% | Oct 11, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +430.30% | Sep 27, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.49
from -1.43
EPS Next Year
-1.73
from -1.49
Revenue Forecast
Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | n/a | n/a | 1.2M | 103.9M | 143.4M | 307.2M |
Avg | n/a | n/a | 374,003 | 46.5M | 58.3M | 178.3M |
Low | n/a | n/a | n/a | 8.8M | 9.8M | 109.5M |
Revenue Growth
Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | - | - | - | 27,667.1% | 208.2% | 426.6% |
Avg | - | - | - | 12,344.8% | 25.4% | 205.6% |
Low | - | - | - | 2,265.0% | -78.9% | 87.6% |
EPS Forecast
EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | -1.46 | -1.27 | -1.48 | -0.39 | 1.28 | 4.17 |
Avg | -1.49 | -1.73 | -1.66 | -1.22 | -0.72 | 1.05 |
Low | -1.50 | -1.92 | -1.96 | -1.96 | -2.16 | -1.18 |
EPS Growth
EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | - | - | - | - | - | - |
Avg | - | - | - | - | - | - |
Low | - | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.